Menu
Back to Journals » OncoTargets and Therapy » Volume 16
Case report
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,029 | Dovepress* | 2,779+ | 64 | 2,843 | |
| PubMed Central* | 250 | 88 | 338 | ||
| Totals | 3,029 | 152 | 3,181 | ||
| *Since 23 June 2023 | |||||
View citations on PubMed Central and Google Scholar